Omni Analytics raised $120M Series C at $1.5B valuation. The ex-Looker team's semantic layer bet: making enterprise AI data trustworthy.
London biotech RQ Bio raised $115M for RQB01, a long-acting antibody aiming to replace annual flu shots for high-risk patients.
Baseten tripled ARR to $600M in one quarter, raised $1.5B at $13B. The inference infrastructure market has arrived.
IN-SPACe selects Astrobase, SatSure and TM2SPACE as first beneficiaries of ₹500 crore Technology Adoption Fund — covering propulsion, Earth observation AI, and satellite navigation
Robotics venture funding hit $23B in the first half of 2026, matching all of 2025. Here is where the money is going — by company, category, and geography.
Golden Analytics raised $14M seed extension led by Insight Partners, totaling $21M. Nearly 1,000 companies requested early access to its AI-native analytics platform with a 'slider of autonomy' that lets users control how much AI drives their workflow.
The global clinical pipeline contains over 22,000 active compounds. Yet 90% of candidates fail. AI, regulatory reform, and new modalities are reshaping how drugs go from target discovery to commercial launch.
Scaled Cognition raised a 100M Series A led by Khosla Ventures to build APT, a model that eliminates AI hallucinations through architectural design, not safety wrappers.
Get daily updates on the technologies and investment opportunities shaping the next decade — from AI infrastructure and autonomous systems to biotech, space, and defence. Curated analysis, no noise.
